Tvardi Therapeutics, Inc. TVRD
0.96 USD +0.09 (+10.79%)
At closeNov 6, 2026, 7:05 PM EST
0.97 +0.01 +1.27%
After hours · Nov 6, 7:05 PM ET
0.8469 Day range 0.98
0.793 52-week range 5.00
- YTD
- -77.73%
- 1 year
- -75.69%
Financial health
Altman Z-Score
-13.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -1.7×
FY 2020 5y median -1.7× FY 2025
P/S 0.0×
FY 2020 5y median 1.0× FY 2025
P/B 1.5×
FY 2020 5y median -0.7× FY 2025
P/FCF -1.4×
FY 2020 5y median -0.5× FY 2025
EV/EBITDA -0.6×
FY 2020 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.6× FY 2025
FCF Yield -73.7%
FY 2020 5y median -206.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 82.1% FY 2025
Operating Margin 0.0%
FY 2020 5y median -386.8% FY 2025
Net Margin 0.0%
FY 2020 5y median -384.1% FY 2025
ROE -87.0%
FY 2020 5y median 189.7% FY 2025
ROIC -126.5%
FY 2020 5y median -139.2% FY 2025
ROA -56.8%
FY 2020 5y median -161.7% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2020 FY 2025
Operating Income 52.0%
FY 2020 FY 2025
EPS (diluted) 93.0%
FY 2020 FY 2025
Free Cash Flow 62.1%
FY 2020 FY 2025
Financial Health
Current Ratio 2.9×
FY 2020 5y median 9.8× FY 2025
Quick Ratio 2.9×
FY 2020 5y median 9.7× FY 2025
Debt / Equity 0.0×
FY 2020 5y median -0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2020 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31